Real-time data on the prognosis of acute ischemic stroke patients in the Tochigi Clinical ObservatioNal registry for 1-year mortality of aCute ischEmic stRoke patieNt (T-CONCERN) study.
Acute ischemic stroke
Cardioembolism
Prognosis
Stroke mortality
Stroke treatment
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
16
03
2022
accepted:
28
08
2022
pubmed:
8
9
2022
medline:
18
11
2022
entrez:
7
9
2022
Statut:
ppublish
Résumé
It is important to gauge mortality in real time following an ischemic stroke. However, there is limited in-hospital and post-discharge clinical data that focuses on the real-time prognosis of acute ischemic strokes. To comprehensively analyze ischemic stroke mortality during a hospital stay and 1 year after the onset of a stroke. Initially, 1514 consecutive acute ischemic stroke patients were admitted to our facility within 7 days after the onset of a stroke. Of these, 1116 patients who were successfully surveyed 1 year after onset were finally analyzed. Baseline, physical, laboratory, and stroke clinical data were recorded and analyzed. The proportion of deaths within 1 year was 14.5%, 4.9% without discharge was and 9.6% after discharge within 1 year. Cardioembolic ischemic strokes were responsible for nearly 50% of the deaths within 1 year while the remaining deaths were due to non-cardioembolic ischemic strokes. After 1 year, survival rate in the hospital decreased significantly, depending on whether the stroke was recurrent or if there was bleeding without a stroke. Our study reveals the real-time survival data 1 year after the onset of a stroke, in-hospital and post-discharge mortality rates, and several issues associated with the treatment of acute ischemic strokes.
Sections du résumé
BACKGROUND
BACKGROUND
It is important to gauge mortality in real time following an ischemic stroke. However, there is limited in-hospital and post-discharge clinical data that focuses on the real-time prognosis of acute ischemic strokes.
PURPOSE
OBJECTIVE
To comprehensively analyze ischemic stroke mortality during a hospital stay and 1 year after the onset of a stroke.
MATERIALS AND METHODS
METHODS
Initially, 1514 consecutive acute ischemic stroke patients were admitted to our facility within 7 days after the onset of a stroke. Of these, 1116 patients who were successfully surveyed 1 year after onset were finally analyzed. Baseline, physical, laboratory, and stroke clinical data were recorded and analyzed.
RESULTS
RESULTS
The proportion of deaths within 1 year was 14.5%, 4.9% without discharge was and 9.6% after discharge within 1 year. Cardioembolic ischemic strokes were responsible for nearly 50% of the deaths within 1 year while the remaining deaths were due to non-cardioembolic ischemic strokes. After 1 year, survival rate in the hospital decreased significantly, depending on whether the stroke was recurrent or if there was bleeding without a stroke.
CONCLUSIONS
CONCLUSIONS
Our study reveals the real-time survival data 1 year after the onset of a stroke, in-hospital and post-discharge mortality rates, and several issues associated with the treatment of acute ischemic strokes.
Identifiants
pubmed: 36071265
doi: 10.1007/s10072-022-06377-1
pii: 10.1007/s10072-022-06377-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6855-6864Informations de copyright
© 2022. Fondazione Società Italiana di Neurologia.
Références
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587
doi: 10.1056/NEJM199512143332401
Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329
doi: 10.1056/NEJMoa0804656
pubmed: 18815396
Berkhemer OA, Fransen PS, Beumer D et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20
doi: 10.1056/NEJMoa1411587
pubmed: 25517348
Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030
doi: 10.1056/NEJMoa1414905
pubmed: 25671798
(1997) Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists’ Collaboration. BMJ 314: 1151–1159
Govan L, Langhorne P, Weir CJ, Collaboratio SUT (2007) Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care? - Further analysis of a systematic review. Stroke 38:2536–2540
doi: 10.1161/STROKEAHA.106.478842
pubmed: 17690313
Asplund K, Berman P, Blomstrand C et al (1997) How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 28:2139–2144
doi: 10.1161/01.STR.28.11.2139
Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151
doi: 10.1056/NEJMoa0905561
pubmed: 19717844
Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891
doi: 10.1056/NEJMoa1009638
pubmed: 21830957
Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992
doi: 10.1056/NEJMoa1107039
pubmed: 21870978
Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093–2104
doi: 10.1056/NEJMoa1310907
pubmed: 24251359
Frankel MR, Morgenstern LB, Kwiatkowski T et al (2000) Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 55:952–959
doi: 10.1212/WNL.55.7.952
pubmed: 11061250
Health, Labour and Welfare Statics Association (2021) J Health Welfare Stat 68:64–68
Han J, Liu J, Wu YK et al (2021) Long-term trends in the stroke prognosis among rural residents in China: a population-based surveillance study. Risk Manag Healthc Policy 14:4013–4021
doi: 10.2147/RMHP.S325822
pubmed: 34594140
pmcid: 8478494
Marini C, De Santis F, Sacco S et al (2005) Contribution of atrial fibrillation to incidence and outcome of ischemic stroke - results from a population-based study. Stroke 36:1115–1119
doi: 10.1161/01.STR.0000166053.83476.4a
pubmed: 15879330
Jørgensen HS, Kammersgaard LP, Nakayama H et al (1999) Treatment and rehabilitation on a stroke unit improves 5-year survival. Commun-Based Study Stroke 30:930–933
pubmed: 10229722
Kammersgaard LP, Jørgensen HS, Reith J et al (2004) Short- and long-term prognosis for very old stroke patients. Copenhagen Stroke Study Age Ageing 33:149–154
doi: 10.1093/ageing/afh052
pubmed: 14960430
Takashima N, Arima H, Kita Y et al (2020) Long-term survival after stroke in 1.4 million Japanese population: shiga Stroke and Heart Attack Registry. J Stroke 22:336–344
doi: 10.5853/jos.2020.00325
pubmed: 33053949
pmcid: 7568968
Health, Labour and Welfare Statics Association (2021) J Health Welfare Stat 68:402
Matsuzono K, Mashiko T, Ozawa T et al (2020) Management effort for delirium and insomnia in patients with acute ischemic stroke (MEDIAS) study. Psychiatry Clin Neurosci 74:279–280
doi: 10.1111/pcn.12979
pubmed: 31930754
Matsuzono K, Mashiko T, Ozawa T et al (2021) Characteristics of aged ischemic stroke patients indicative of cardioembolism. J Thromb Thrombolys 51:522–529
doi: 10.1007/s11239-020-02198-1
Gordon DL, Bendixen BH, Adams HP Jr, Clarke W, Kappelle LJ, Woolson RF (1993) Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. TOAST Investigators Neurol 43:1021–1027
Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:2064–2089
doi: 10.1161/STR.0b013e318296aeca
pubmed: 23652265
Wang W, Wang D, Liu H et al (2017) Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc Neurol 2:132–139
doi: 10.1136/svn-2017-000098
pubmed: 28989803
pmcid: 5628381
Andre C, Curioni CC, Braga da Cunha C, Veras R (2006) Progressive decline in stroke mortality in Brazil from 1980 to 1982, 1990 to 1992, and 2000 to 2002. Stroke 37:2784–2789
doi: 10.1161/01.STR.0000244768.46566.73
pubmed: 17008629
Lecoffre C, de Peretti C, Gabet A et al (2017) National trends in patients hospitalized for stroke and stroke mortality in France, 2008 to 2014. Stroke 48:2939–2945
doi: 10.1161/STROKEAHA.117.017640
pubmed: 28970279
Thijs VN, Brachmann J, Morillo CA et al (2016) Predictors for atrial fibrillation detection after cryptogenic stroke: results from CRYSTAL AF. Neurology 86:261–269
doi: 10.1212/WNL.0000000000002282
pubmed: 26683642
pmcid: 4733152
Anan Y, Mashiko T, Matsuzono K et al (2022) Coexisting of aortic arch atheroma and atrial fibrillation for short-term recurrence and poor functional outcome in acute stroke. Neurol Sci 43:2387–2396
doi: 10.1007/s10072-021-05722-0
pubmed: 34748067
Naccarelli GV, Varker H, Lin J, Schulman KL (2009) Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 104:1534–1539
doi: 10.1016/j.amjcard.2009.07.022
pubmed: 19932788
Fang MC, Singer DE, Chang Y et al (2005) Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112:1687–1691
doi: 10.1161/CIRCULATIONAHA.105.553438
pubmed: 16157766
pmcid: 3522521
Yoshimura S, Koga M, Sato S et al (2018) Two-year outcomes of anticoagulation for acute ischemic stroke with nonvalvular atrial fibrillation- SAMURAI-NVAF study. Circ J 82:1935–1942
doi: 10.1253/circj.CJ-18-0067
pubmed: 29863095
Saji N, Sakurai T, Ito K et al (2018) Protective effects of oral anticoagulants on cerebrovascular diseases and cognitive impairment in patients with atrial fibrillation: protocol for a multicentre, prospective, observational, longitudinal cohort study (Strawberry study). BMJ Open 8:e021759
doi: 10.1136/bmjopen-2018-021759
pubmed: 30478106
pmcid: 6254414
Matsuzono K, Suzuki M, Miura K et al (2021) Internal jugular vein velocity and spontaneous echo contrast correlate with Alzheimer’s disease and cognitive function. J Alzheimers Dis 84:787–796
doi: 10.3233/JAD-210490
pubmed: 34602471
Sakamoto Y, Nishiyama Y, Iwasaki YK et al (2019) Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study. J Cardiol 74:539–542
doi: 10.1016/j.jjcc.2019.06.002
pubmed: 31337525
Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S (2011) Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 123:417–424
doi: 10.1161/CIRCULATIONAHA.110.976449
pubmed: 21242484
Hart RG, Connolly SJ, Mundl H (2018) Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 378:2191–2201
doi: 10.1056/NEJMoa1802686
pubmed: 29766772
Diener HC, Sacco RL, Easton JD et al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380:1906–1917
doi: 10.1056/NEJMoa1813959
pubmed: 31091372
Jackson C, Sudlow C (2005) Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 128:2507–2517
doi: 10.1093/brain/awh636
pubmed: 16195245
Lund RW (2014) Lacunar infarction, mortality over time and mortality relative to other ischemic strokes. J Insur Med 44:32–37
pubmed: 25004596
Aoki J, Kimura K, Morita N et al (2017) YAMATO study (tissue-type plasminogen activator and edaravone combination therapy). Stroke 48:712–719
doi: 10.1161/STROKEAHA.116.015042
pubmed: 28119434
ukic-Panin V, Deguchi K, Yamashita T et al (2010) Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage. Curr Neurovasc Res 7:319–329
doi: 10.2174/156720210793180747